Biotech & Longevity

Biology is becoming programmable. Explore startups using AI for drug discovery, engineering gene therapies, and unlocking the science of human longevity.

60
Startups
$194.5B
Total Funding
6
Sector Queries
Updated Hourly

Top Startups in Biotech & Longevity

Thermo Fisher Scientific

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Life Sciences
Analytical Instruments
Laboratory Equipment
$5.5B
Waltham
Ipsen

Ipsen

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Biotech
MedTech
HealthTech
N/A
Paris
St. Jude Children’s Research Hospital

St. Jude Children’s Research Hospital

A leading children's research hospital dedicated to treating and curing childhood catastrophic diseases.

Healthcare
Biotechnology
Non-profit
$63M
Memphis
Neuralink

Neuralink

Neuralink develops brain-computer interface implants that enable direct communication between the human brain and computers, targeting paralysis and neurological conditions.

Neurotechnology
Brain-Computer Interface
Medical Devices
$650M

Veeva Systems

Cloud-based software, data, and consulting solutions for the global life sciences industry.

SaaS
Cloud Computing
Life Sciences
$7M
Pleasanton
Amgen

Amgen

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Biotech
MedTech
HealthTech
$40M
Thousand Oaks

Supernus Pharmaceuticals

Biopharmaceutical company developing and commercializing CNS disease treatments.

Biotechnology
Pharmaceuticals
Healthcare
$18M
Rockville

Galderma Group

A global pure-play dermatology company focused on injectable aesthetics, dermatological skincare, and therapeutic medicine.

Healthcare
Biotechnology
Pharmaceuticals
$63M
Zug
Abcam

Abcam

Global supplier of life science research tools, including antibodies, reagents, and assays.

Biotechnology
Life Sciences
Discovery Tools
$257M
Cambridge

Founders Fund

Venture capital firm investing in revolutionary technologies and ambitious founders tackling big problems.

Venture Capital
Technology
Artificial Intelligence
$19.9B
San Francisco

Agilent Technologies

Global leader in life sciences, diagnostics, and applied chemical markets.

Life Sciences
Diagnostics
Analytical Instruments
$52.6B
Santa Clara
Alcolase

Alcolase

Enzyme-based technology to break down alcohol in the stomach.

Biotechnology
Health
Pharmaceuticals
$14.9B
Copenhagen

Blackstone Life Sciences

Accelerating the development of breakthrough new medicines and medical technologies.

Life Sciences
Biotechnology
Pharmaceuticals
$6.2B
New York
WuXi AppTec

WuXi AppTec

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

Drug Discovery
Contract Research Organization (CRO)
Contract Development and Manufacturing Organization (CDMO)
$40M
Shanghai
Moderna

Moderna

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology
mRNA Technology
Vaccines
$4.4B
Cambridge
BioNTech

BioNTech

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology
Drug Discovery
Oncology
$975M
Mainz
Healthpeak Properties

Healthpeak Properties

A leading owner, operator, and developer of real estate for healthcare discovery and delivery.

Healthcare
Real Estate
Life Sciences
$20.0B
Denver
Index Ventures

Index Ventures

Global venture capital firm backing ambitious entrepreneurs from seed to IPO across technology and life sciences.

Venture Capital
Growth Capital
Enterprise Software
$9.1B
London
Allergan

Allergan

A global pharmaceutical company focused on developing and marketing innovative treatments.

Biotech
MedTech
HealthTech
$30.1B
Dublin
LabCorp

LabCorp

Global life sciences company providing diagnostic and biopharma laboratory services.

HealthTech
MedTech
Genomics
$2.9B
Burlington
BeiGene

BeiGene

A global oncology company developing and commercializing innovative cancer treatments.

Biotech
MedTech
HealthTech
$358M
Cambridge
Kilo

Kilo

A high-velocity venture studio co-founding and investing in startups across health, longevity, beauty, and travel.

Health
Longevity
Beauty
$10M
Vilnius
Isomorphic Labs

Isomorphic Labs

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Drug Discovery
Biotechnology
AI-Driven Drug Discovery
$4.7B
London
Impossible Foods

Impossible Foods

Develops plant-based meat alternatives that mimic the taste, texture, and aroma of conventional meat.

FoodTech
Cellular Agriculture
Plant-Based Meat
$2.0B
Redwood City

Kite Pharma

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology
Pharmaceuticals
Oncology
$421M
Santa Monica
Immunai

Immunai

Healthcare
Immunology
Data
$295M
Ultima Genomics

Ultima Genomics

Life Sciences
Biotech
Bioinformatics
$600M
CytoReason

CytoReason

Healthcare
Drug Discovery
Clinical Development
$128M

CRISPR Therapeutics

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology
Gene Editing
Therapeutics
$547M
Zug

Juno Therapeutics

Biotechnology company focused on developing cancer immunotherapies.

Biotechnology
Pharmaceuticals
Cancer Immunotherapy
$317M
Seattle
ŌURA

ŌURA

Wearable technology company developing smart rings for comprehensive sleep, activity, and health tracking.

Wearable Technology
HealthTech
Biotechnology
N/A
San Francisco
Stryker Corporation

Stryker Corporation

A global leader in medical technology, developing innovative solutions for healthcare.

Medical Devices
Healthcare Technology
Biotechnology
N/A
Kalamazoo
PCI Pharma Services

PCI Pharma Services

A leading global contract development and manufacturing organization (CDMO) for innovative biologic and small molecule therapies.

Pharmaceuticals
Biotechnology
Contract Manufacturing
$63M
Philadelphia
Cradle

Cradle

Cradle Bio B.V. is a Dutch–Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Biotech
HealthTech
AI-Driven Protein Design
$102M
Amsterdam
Altos Labs

Altos Labs

Biotechnology company focused on cellular rejuvenation to reverse disease and extend healthspan.

Biotechnology
HealthTech
Longevity
$3.8B
Redwood City
Dassault Systèmes

Dassault Systèmes

Global leader in 3D design, 3D digital mock-up, and product lifecycle management software solutions.

Software
Artificial Intelligence
3D Design
N/A
Vélizy-Villacoublay
Jacobs

Jacobs

Global technical professional services firm providing engineering, consulting, and technology solutions.

Engineering
Consulting
Infrastructure
N/A
Dallas
IQVIA

IQVIA

Leveraging AI and advanced analytics to drive innovation in healthcare and life sciences.

Healthcare
Life Sciences
Data Analytics
N/A
Durham
Curia

Curia

Global contract research, development, and manufacturing organization for pharmaceutical and biopharmaceutical industries.

Contract Research Organization
Contract Development and Manufacturing Organization (CDMO)
Drug Discovery
$56M
Albany

Cystic Fibrosis Foundation

A leading organization dedicated to curing and treating cystic fibrosis.

Biotechnology
Healthcare
Non-profit
$9M
Bethesda
Chai Discovery

Chai Discovery

AI-powered drug discovery platform using foundation models for molecular design.

Artificial Intelligence
Biotechnology
Drug Discovery
$2M
San Francisco

Causaly

AI-powered knowledge discovery for life sciences.

Biotechnology
Artificial Intelligence
Drug Discovery
$63M
London
Calyxo

Calyxo

Redefining kidney stone treatment with an aspiration-based stone removal system.

Medical Devices
HealthTech
Biotechnology
$151M
Pleasanton
Periodic Labs

Periodic Labs

AI-powered materials science and discovery platform to accelerate scientific breakthroughs.

Artificial Intelligence
Materials Science
Drug Discovery
$300M
San Francisco
Schrödinger

Schrödinger

Physics-based software platform for molecular discovery and design in life and materials sciences.

Drug Discovery
Biotech
Pharmaceuticals
$320M
New York
Benchling

Benchling

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

BIO + LIFE SCIENCES
Biotech
MedTech
$419M
San Francisco
Xaira Therapeutics

Xaira Therapeutics

AI-powered biotech platform using protein design to discover novel therapeutic molecules.

Artificial Intelligence
Biotechnology
Drug Discovery
$1.0B
San Francisco
Generate Biomedicines

Generate Biomedicines

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Biotechnology
Drug Discovery
HealthTech
$693M
Somerville
Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc.

A global contract research organization providing essential drug discovery and development services.

Contract Research Organization
Drug Discovery
Preclinical Development
$1.0B
Wilmington
Valar AI

Valar AI

AI-driven diagnostics company predicting cancer treatment response from pathology slides.

Fintech
Venture Capital
Payments
$2.4B
תל אביב - יפו

Lakestar

European venture capital firm focused on early-stage technology companies.

Venture Capital
Technology
Deep Tech
$1.5B
Berlin
Azurity Pharmaceuticals

Azurity Pharmaceuticals

Azurity Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing high-quality, affordable liquid medications.

Pharmaceuticals
Healthcare
Biotechnology
$1.1B
Woburn
Celerion

Celerion

A global leader in clinical pharmacology and bioanalytical sciences.

Biotechnology
Pharmaceuticals
Healthcare
$45M
Lincoln
NNIT

NNIT

Global IT services and consulting company for life sciences and enterprise businesses.

IT Services
IT Consulting
Digital Transformation
$13M
Copenhagen

Denali Therapeutics

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Biotech
HealthTech
Drug Discovery
$1.0B
South San Francisco

MacroGenics

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Biotech
MedTech
HealthTech
$14M
Rockville

ANI

Diversified biopharmaceutical company focused on rare diseases and generics.

Biopharmaceutical
Rare Disease
Ophthalmology
$3.2B
Princeton
Altasciences

Altasciences

Integrated drug development solutions for pharmaceutical and biotechnology companies, from preclinical to clinical trials.

Biotech & Longevity
Drug Discovery
Clinical Trials
$79M
Laval
Recursion

Recursion

AI-driven drug discovery platform industrializing the process to radically improve patient lives.

BIO + LIFE SCIENCES
Drug Discovery
Biotechnology
N/A
Salt Lake City
Owkin

Owkin

AI company using federated learning to solve biological complexity and accelerate drug discovery.

Artificial Intelligence
Biotechnology
Healthcare
$80M
New York
Biotech is being reinvented by software. AI-first drug discovery companies (Recursion, Insitro, Insilico Medicine) have raised $10B+ combined, and the first AI-discovered drugs are entering Phase II clinical trials. The promise: reducing the average $2.6B cost and 10-year timeline of bringing a drug to market by 50-70%. The longevity sector has gone from fringe to mainstream. Altos Labs ($3B from Jeff Bezos), Calico (Google), and Unity Biotechnology are pursuing cellular reprogramming, senolytic therapies, and epigenetic clocks. Bryan Johnson's Blueprint protocol has turned anti-aging into a consumer movement. The science is real: rapamycin, metformin, and NAD+ precursors show genuine promise in clinical settings. What makes modern biotech different from the last generation is the convergence of AI, CRISPR, and cloud biology. Startups can now screen millions of compounds computationally, edit genes with precision, and run experiments on robotic lab platforms (Strateos, Emerald Cloud Lab). This dramatically reduces the capital required to reach clinical-stage data, making biotech fundable for VCs who previously avoided the space. The TAM is healthcare itself — a $12T global market.

Explore More Startups

Search any AI startup in our database